Who are Standard of Care Oral antipsychotics's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Sertraline + Olanzapine, ziprasidone or olanzapine, Aripiprazole; Quetiapine, Risperidone high dose, Perospirone hydrochloride tablets, Antipsychotic Maintenance.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/standard-of-care-oral-antipsychotics.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Standard of Care Oral antipsychotics — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Standard of Care Oral antipsychotics (Standard of Care Oral antipsychotics) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antipsychotic. Area: Psychiatry.

marketed Antipsychotic Dopamine D2 receptor; Serotonin 5-HT2A receptor Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Standard of Care Oral antipsychotics (Standard of Care Oral antipsychotics) — University of Utah. Standard of care oral antipsychotics block dopamine and/or serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Standard of Care Oral antipsychotics TARGET	Standard of Care Oral antipsychotics	University of Utah	marketed	Antipsychotic	Dopamine D2 receptor; Serotonin 5-HT2A receptor
Sertraline + Olanzapine	Sertraline + Olanzapine	Weill Medical College of Cornell University	marketed	SSRI + atypical antipsychotic combination	Serotonin transporter (SERT); dopamine D2 receptor; serotonin 5-HT2A receptor
ziprasidone or olanzapine	ziprasidone or olanzapine	Medical University of Vienna	marketed	Atypical antipsychotic	Dopamine D2 receptor; Serotonin 5-HT2A receptor
Aripiprazole; Quetiapine	Aripiprazole; Quetiapine	Taichung Veterans General Hospital	marketed	Atypical antipsychotic combination	Dopamine D2 receptor; Serotonin 5-HT2A receptor; Serotonin 5-HT1A receptor
Risperidone high dose	Risperidone high dose	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	marketed	Atypical antipsychotic	Dopamine D2 receptor; Serotonin 5-HT2A receptor
Perospirone hydrochloride tablets	Perospirone hydrochloride tablets	Shanghai Mental Health Center	marketed	Atypical antipsychotic	Dopamine D2 receptor; Serotonin 5-HT2A receptor
Antipsychotic Maintenance	Antipsychotic Maintenance	University College, London	marketed	Antipsychotic (typical or atypical)	Dopamine D2 receptor; serotonin 5-HT2A receptor (varies by specific agent)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antipsychotic class)

Fundación Pública Andaluza Progreso y Salud · 1 drug in this class
Ludwig-Maximilians - University of Munich · 1 drug in this class
Technical University of Munich · 1 drug in this class
University of Utah · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Standard of Care Oral antipsychotics — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-of-care-oral-antipsychotics. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab